Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on November 20, 2008

Stroke. 2008
Published online before print November 20, 2008, doi: 10.1161/STROKEAHA.108.528588
A more recent version of this article appeared on February 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/2/610    most recent
STROKEAHA.108.528588v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valerio, A.
Right arrow Articles by Nisoli, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valerio, A.
Right arrow Articles by Nisoli, E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCOSE
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction
Right arrow Neuroprotectors

Submitted on June 12, 2008
Accepted on June 19, 2008

Leptin Is Induced in the Ischemic Cerebral Cortex and Exerts Neuroprotection Through NF-{kappa}B/c-Rel–Dependent Transcription

Alessandra Valerio MD; Marta Dossena PhD; Paola Bertolotti MD; Flora Boroni PhD; Ilenia Sarnico PhD; Giuseppe Faraco MD; Alberto Chiarugi MD; Andrea Frontini PhD; Antonio Giordano MD; Hsiou-Chi Liou PhD; Maria Grazia De Simoni PhD; PierFranco Spano PhD; Michele O. Carruba MD, PhD; Marina Pizzi PhD; and Enzo Nisoli MD, PhD*

From the Division of Pharmacology, Department of Biomedical Sciences and Biotechnologies (A.V., F.B., I.S., P.F.S., M.P.), University of Brescia, Brescia, Italy; the Center for Study and Research on Obesity, Department of Pharmacology, Chemotherapy and Medical Toxicology (A.V., M.D., P.B., M.O.C., E.N.), University of Milan, Milan, Italy; the Department of Pharmacology (G.F., A.C.), University of Florence, Florence, Italy; the Institute of Normal Human Morphology (A.F., A.G.), Marche Polytechnic University, Ancona, Italy; the Department of Immunology (H.-C.L.), Weill Medical College of Cornell University, New York, NY; the Laboratory of Inflammation and Nervous System Diseases (M.G.D.S.), Mario Negri Institute, Milan, Italy; and the Istituto Auxologico Italiano (M.O.C., E.N.), Milan, Italy.

* To whom correspondence should be addressed. E-mail: enzo.nisoli{at}unimi.it.

Background and Purpose—Leptin is an adipose hormone endowed with angiopoietic, neurotrophic, and neuroprotective properties. We tested the hypothesis that leptin might act as an endogenous mediator of recovery after ischemic stroke and investigated whether nuclear transcription factors {kappa}B activation is involved in leptin-mediated neuroprotection.

Methods—The antiapoptotic effects of leptin were evaluated in cultured mouse cortical neurons from wild-type or NF-{kappa}B/c-Rel-/- mice exposed to oxygen–glucose deprivation. Wild-type, c-Rel-/- and leptin-deficient ob/ob mice were subjected to permanent middle cerebral artery occlusion. Leptin production was measured in brains from wild-type mice with quantitative reverse transcriptase–polymerase chain reaction and immunostaining. Mice received a leptin bolus (20 µg/g) intraperitoneally at the onset of ischemia.

Results—Leptin treatment activated the nuclear translocation of nuclear transcription factors {kappa}B dimers containing the c-Rel subunit, induced the expression of the antiapoptotic c-Rel target gene Bcl-xL in both control and oxygen–glucose deprivation conditions, and counteracted the oxygen–glucose deprivation-mediated apoptotic death of cultured cortical neurons. Leptin-mediated Bcl-xL induction and neuroprotection against oxygen–glucose deprivation were hampered in cortical neurons from c-Rel-/- mice. Leptin mRNA was induced and the protein was detectable in microglia/macrophage cells from the ischemic penumbra of wild-type mice subjected to permanent middle cerebral artery occlusion. Ob/ob mice were more susceptible than wild-type mice to the permanent middle cerebral artery occlusion injury. Leptin injection significantly reduced the permanent middle cerebral artery occlusion-mediated cortical damage in wild-type and ob/ob mice, but not in c-Rel-/- mice.

Conclusions—Leptin acts as an endogenous mediator of neuroprotection during cerebral ischemia. Exogenous leptin administration protects against ischemic neuronal injury in vitro and in vivo in a c-Rel-dependent manner.


Key words: animal models • apoptosis • brain ischemia • leptin • NF-{kappa}B




This article has been cited by other articles:


Home page
StrokeHome page
K. Tsuda
Neuroprotective Effects of Leptin and Nitric Oxide Against Cerebral Ischemia
Stroke, May 1, 2009; 40(5): e406 - e406.
[Full Text] [PDF]


Home page
StrokeHome page
A. Valerio and E. Nisoli
Response to Letter by Tsuda
Stroke, May 1, 2009; 40(5): e407 - e407.
[Full Text] [PDF]